Kuat Oshakbayev

Prof. Kuat Oshakbayev

orcid
University Medical Center (Astana)

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2022 in Journal of Infection and Public Health
Verified
Journal Article
Open access
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
ZZZulfiya Zhankalova
Zulfiya Zhankalova
MGMeruyert Gazaliyeva
Meruyert Gazaliyeva
KMKhalit Mustafin
Khalit Mustafin
GBGulnara Bedelbayeva
Gulnara Bedelbayeva
ATAttila Tordai
Attila Tordai
The spread of COVID-19 depends on a lot of social and economic factors. The aim: to study the influence of country’s gross domestic product, population prevalence of overweight/ obesity, NCD mortality, and vaccination on COVID-19 morbidity and mortality rates. A cross-sectional study with two phases: correlation-regression interrelations in 1) all world countries; 2) all world non-island countries. The study includes the following data from 218 world countries: COVID-19 morbidity/mortality rates, GDP per capita, the prevalence of overweight/ obesity, NCD mortality among adults (both sexes), people fully vaccinated against COVID-19. An average percentage of the prevalence of overweight among adults in world countries by 2019 was 47.31 ± 15.99%, obesity 18.34 ± 9.64%, while the prevalence by 2016 were 39% and 13%, respectively. Overweight and obesity among adults during three years grew by 21.2% and 40.8%, respectively. Data from the world countries provide significant correlations (p < 0.0001) between COVID-19 morbidity, and: GDP (r = 0.517), overweight (r = 0.54), obesity (r = 0.528), NCD mortality (r = 0.537); COVID-19 mortality, and: GDP (r = 0.344), overweight (r = 0.514), obesity (r = 0.489), NCD mortality (r = 0.611); GDP, and: overweight (r = 0.507), obesity (r = 0.523), NCD mortality (r = 0.35), fully vaccinated people (r = 0.754). An increase in fully vaccinated people, from 3% to 30% of world population, decreases new confirmed COVID-19 cases, although the dependence was not significant (p = 0.07). Data from non-island world countries provides more highly significant correlations (p < 0.0001) between COVID-19 morbidity, and: GDP (r = 0.616), overweight (r = 0.581), obesity (r = 0.583); COVID-19 mortality, and: GDP (r = 0.43), overweight (r = 0.556), obesity (r = 0.539); GDP, and: overweight (r = 0.601), obesity (r = 0.633). The differences of correlation coefficients between data of 176 world countries and data of 143 world non-island countries were not significant (Z-scores 0.05). The study provides evidence of a significant impact of overweight/obesity prevalence on the increase in COVID-19 morbidity/mortality. Countries with higher GDP have a high overweight/obesity prevalence and possibility to get vaccinated.

28 November 2018 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
BBBakytzhan Bimbetov
Bakytzhan Bimbetov
KMKenzhegul Manekenova
Kenzhegul Manekenova
GBGulnara Bedelbayeva
Gulnara Bedelbayeva
KMKhalit Mustafin
Khalit Mustafin
BDBibazhar Dukenbayeva
Bibazhar Dukenbayeva
Objective: To evaluate the effectiveness of the fast weight loss method on liver steatosis, fibrosis, inflammation, glycemic and lipids features and body composition in patients with severe Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes (T2D). Methods: A 24-week open prospective randomised controlled clinical trial including 80 adult patients (aged 40-65 years) was performed. The patients after randomisation were divided in two groups: Main group followed the fast weight loss method; Control group received conventional drug treatment. The fast weight loss method included calorie restriction, salt intake, walking and sexual self-restraint. The conventional drug therapy included Vitamin E, Orlistat, Pioglitazone hydrochloride, Atorvastatin, Lisinopril, benzodiazepines and anti-inflammatory agents. Primary endpoints: ultrasound and histology suggestive of steatohepatitis, hepatic enzymes, weight loss, 2-hour oral glucose tolerance test, HbA1c. Secondary endpoints: blood pressure, lipids. Results: 83% patients completed the study. In Main weight lost 7-16 kg (10-20% from baseline) for 8-10 weeks. In Main weight lost due to reduction of fat mass only. Main vs. Controls showed higher decrease in fat mass from baseline (P < 0.001). Ultrasound imaging and liver histological scoring system evidenced significant improvement on liver steatosis/fibrosis in Main (P < 0.001). In Main vs. Controls weight lost at 24 weeks led to positive laboratory changes in ALT, AST, 2-hour OGTT, HbA1c, HOMA-IR, BP, cholesterol, triglycerides, bilirubin total, blood hemoglobin (P = 0.01). The fast weight loss in the patients adequately led to decrease in symptomatic drugs up to complete abolition. Conclusions: The study showed benefits of the fast weight loss method improving in steatosis/fibrosis, biochemical/metabolic outcomes in patients with severe NASH and T2D.

1 January 2014 in American Journal of Case Reports
Verified
Journal Article
Open access
PDF file
BDBibazhar Abayevna Dukenbayeva
Bibazhar Abayevna Dukenbayeva
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
KAKenneth Alibek
Kenneth Alibek
IPIgor Olegovich Ponomarev
Igor Olegovich Ponomarev
NUNurlybek Nurlanovich Uderbayev
Nurlybek Nurlanovich Uderbayev
Female, 41 FINAL DIAGNOSIS: Ovarian carcinoma Symptoms: Ascites • hepatomegaly • weight loss - Clinical Procedure: - Specialty: Oncology. Unusual or unexpected effect of treatment. The aim of this case report is to present the results of treatment of end-stage ovarian carcinoma in a 41-year-old women using weight loss therapy. We describe the case of a female aged 41 years with epithelial invasive ovarian cancer of III-IV stage, T3N2M1. Concurrent diseases were: abdominal carcinomatosis; hepatomegaly; ascites; condition after laparocentesis and skin-abdominal fistula; condition after 6 courses of neo-adjuvant polychemotherapy; hypertension II stage, risk factor of 3-4; dyslipidemia; and metabolic syndrome. A weight loss method based on a very-low-calorie diet and physical activity was used. Body weight was reduced from 74 kg to 53 due to loss of adipose tissue after 6 months of therapy. At the same time, the percentages of water and muscle tissue were increased significantly. While overweight was reducing, clinical, laboratory, and instrumental results were improving. As a result of the weight loss therapy, about ≈100 mm-sized ovarian cancer was transformed into smaller-sized ovarian cysts. An analgesic effect was also achieved without use of narcotic or non-narcotic analgesics. These cyto-reversible processes were documented by laboratory and instrumental data. The mechanisms behind these differences remain to be elucidated. Future research with a larger study cohort and longer follow-up is needed to further investigate the role of caloric restriction diet in cancer cell changes in ovarian cancer.

31 January 2017 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
BDBibazhar Dukenbayeva
Bibazhar Dukenbayeva
GTGulnar Togizbayeva
Gulnar Togizbayeva
ADAigul Durmanova
Aigul Durmanova
MGMeruyert Gazaliyeva
Meruyert Gazaliyeva
AIAlisher Idrissov
Alisher Idrissov
The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. At 24 weeks, patients in Main weight lost between 8-18 kg (10–21%); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0%, cortisol levels decreased by 40.7%, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes. ClinicalTrials.gov Identifier: NCT02503865 . Retrospectively registered November 2015.

25 November 2015 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
BDBibazhar Dukenbayeva
Bibazhar Dukenbayeva
NONurzhan Otarbayev
Nurzhan Otarbayev
GTGulnar Togizbayeva
Gulnar Togizbayeva
NTNariman Tabynbayev
Nariman Tabynbayev
POPernekul Oshakbayev
Pernekul Oshakbayev
The prevalence and burden of atherosclerotic (AS) diseases are increasing during the last twenty years. Some studies show a close relationship between overweight and AS, but influence on AS diseases of different weight loss methods are still studying. The purpose of the research was to study the effectiveness of a weight loss program in AS patients in randomized controlled trial, and to develop a conception of evolution of AS. A randomized controlled prospective clinical trial including 97 people, from them 71 patients with various AS manifestations. Patients were divided in 2 subgroups for non-drug weight loss program, and conventional drug therapy. The weight loss program included calorie restriction with 100–150 kcal/day, fat-free vegetables, salt diet, and optimum physical activity. Statistical analysis was performed using SPSS for Windows version 17.0. The weight loss subgroup lost ranging between 7-20 % from an initial weight (P = 0.016). Weight loss was achieved due to fatty mass reduction only (P = 0.005). Hemoglobin levels (P < 0.001), bone mineral density (P < 0.001), percentages of water (P = 0.006) and muscle masses (P = 0.0038) were increased in weight loss subgroup. Ejection fraction (P < 0.0001), systolic output (P < 0.0001) were increased in patients with coronary artery disease. The weight loss program led to a decrease in symptomatic drugs doses up to total abolition. A conception of AS was developed. The weight loss program treated the AS diseases; improved laboratory and instrumental parameters, decreased symptomatic drugs doses. AS development is a logical way of ontogenetic ageing of body fat. ClinicalTrials.gov NCT01700075 . State registration is # 0109RK000079, code is O.0475 at the National Center for Scientific and Technical Information of the Republic of Kazakhstan.

1 January 2025 in Translational Medicine of Aging
Verified
Journal Article
Open access
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
ADAigul Durmanova
Aigul Durmanova
ANAltay Nabiyev
Altay Nabiyev
ASAntonio Sarria-Santamera
Antonio Sarria-Santamera
AIAlisher Idrissov
Alisher Idrissov
GKGani Kuttymuratov
Gani Kuttymuratov